Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Initial Results of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer and Lynch Syndrome.

The American surgeon - 1 Oct 2015

Howarth Dt R, Lum Sharon S, Esquivel Pamela, Garberoglio Carlos A, Senthil Maheswari, Solomon Naveenraj L

Abstract excerpt

Multigene panel testing for hereditary cancer risk has recently become commercially available; however, the impact of its use on patient care is undefined. We sought to evaluate results from implementation of panel testing in a multidisciplinary cancer center. We performed a retrospective review of consecutive patients undergoing genetic testing after initiating use of multigene panel testing at Loma Linda...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Colorectal Neoplasms, Hereditary Nonpolyposis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Follow-Up Studies

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Genetic Predisposition to Disease

Share to Genetic Testing

Share to Ovarian Neoplasms

Source

Identifiers

PMID: 26463285

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Initial Results of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer and Lynch Syndrome.PMID 26463285Read ↗

Multigene Testing for Hereditary Cancer: When, Why, and How.Semantic proximity Read ↗

Multi-gene panel testing for hereditary cancer susceptibility in a rural Familial Cancer Program.Semantic proximity Read ↗

A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patientsSemantic proximity Read ↗

Evaluation of a 27-gene inherited cancer panel across 630 consecutive patients referred for testing in a clinical diagnostic laboratorySemantic proximity Read ↗

Mutation prevalence tables for hereditary cancer derived from multigene panel testing.Semantic proximity Read ↗

Increased yield of actionable mutations using multi-gene panels to assess hereditary cancer susceptibility in an ethnically diverse clinical cohort.Semantic proximity Read ↗

Effects of Cancer Genetic Panel Testing on at-Risk Individuals.Semantic proximity Read ↗

Consideration for Multigene Panel Testing Outside of Cancer-Specific Genetic Testing.Semantic proximity Read ↗

Mutation prevalence tables for hereditary cancer derived from multi-gene panel testingSemantic proximity Read ↗

Clinical testing with a panel of 25 genes associated with increased cancer risk results in a significant increase in clinically significant findings across a broad range of cancer histories.Semantic proximity Read ↗

Cancer risk assessment using genetic panel testing: considerations for clinical application.Semantic proximity Read ↗

Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO Guideline.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.